Position in UTHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,056,899
-$39,087,497 QoQ
Shares Held
9,333
-87.5% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#246
of 870 holders
Holding Since
Mar 2021
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Derivatives in UTHR
reported options exposure · as of Jun 30, 2026CallValue
$198,634,878
CallShares
366,600
PutValue
$204,920,106
PutShares
378,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Caption Management, LLC holds $32,819,609 across 14 Drug Manufacturers - Specialty & Generic names. UTHR ranks #2 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
258,331 | $8,752,254 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
9,333 | $5,056,899 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
29,500 | $4,971,930 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
40,000 | $3,311,200 | |
| 5 | PRGO |
PERRIGO Co plc
|
253,459 | $2,633,439 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
25,000 | $1,598,750 | |
| 7 | XERS |
Xeris Biopharma Holdings, Inc.
|
197,863 | $1,567,074 | |
| 8 | EOLS |
Evolus, Inc.
|
216,316 | $1,501,233 |
All Filings in UTHR
Export CSV
36 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $204,920,106 | 378,200 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $198,634,878 | 366,600 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $5,056,899 | 9,333 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $243,121,800 | 410,000 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $44,144,396 | 74,445 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $395,636,256 | 667,200 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $77,862,550 | 159,800 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $108,559,300 | 222,800 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $26,838,217 | 55,081 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $129,871,258 | 309,800 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $106,311,656 | 253,600 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $16,566,759 | 39,519 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $18,160,520 | 63,200 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $5,229,770 | 18,200 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $14,396,235 | 50,100 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $13,502,226 | 43,800 | Put | Sole | 2025-05-15 | |
| 2025-03-31 | $375,781 | 1,219 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $13,872,150 | 45,000 | Call | Sole | 2025-05-15 | |
| 2024-12-31 | $7,056,800 | 20,000 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $7,056,800 | 20,000 | Put | Sole | 2025-02-14 | |
| 2024-06-30 | $6,371,000 | 20,000 | Put | Sole | 2024-08-14 | |
| 2024-06-30 | $10,830,700 | 34,000 | Call | Sole | 2024-08-14 | |
| 2023-09-30 | $3,388,050 | 15,000 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $3,388,050 | 15,000 | Put | Sole | 2023-11-14 | |
| 2023-06-30 | $3,311,250 | 15,000 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $3,311,250 | 15,000 | Put | Sole | 2023-08-14 | |
| 2022-09-30 | $12,562,800 | 60,000 | Call | Sole | 2022-11-14 | |
| 2022-09-30 | $20,938,000 | 100,000 | Put | Sole | 2022-11-14 | |
| 2022-09-30 | $1,046,900 | 5,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,712,800 | 20,000 | Call | Sole | 2022-08-15 | |
| 2022-06-30 | $4,712,800 | 20,000 | Put | Sole | 2022-08-15 | |
| 2021-12-31 | $4,321,600 | 20,000 | Put | Sole | 2022-02-11 | |
| 2021-12-31 | $4,321,600 | 20,000 | Call | Sole | 2022-02-11 | |
| 2021-09-30 | $9,967,320 | 54,000 | Put | Sole | 2021-11-12 | |
| 2021-09-30 | $4,787,451 | 25,937 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $2,509,050 | 15,000 | Call | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||